Trademark: 97260110
Status Date
Monday, November 20, 2023
Filing Date
Wednesday, February 9, 2022
5 Hemostatic agent for human medical use which controls bleeding by bonding with blood at wound sites; hemostatic agents, namely, powders which control bleeding by bonding with blood at wound sites
Jan 4, 2024
Assigned To Examiner
Nov 20, 2023
Report Completed Suspension Check Case Still Suspended
May 22, 2023
Report Completed Suspension Check Case Still Suspended
Nov 22, 2022
Notification Of Letter Of Suspension E-Mailed
Nov 22, 2022
Letter Of Suspension E-Mailed
Nov 22, 2022
Suspension Letter Written
Nov 22, 2022
Examiner's Amendment Entered
Nov 22, 2022
Notification Of Examiners Amendment E-Mailed
Nov 22, 2022
Examiners Amendment E-Mailed
Nov 22, 2022
Examiners Amendment -Written
Nov 22, 2022
Assigned To Examiner
Feb 15, 2022
New Application Office Supplied Data Entered
Feb 12, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24